A New Chapter of the Coronavirus

A New Chapter of the Coronavirus

Up next

Trump Wants to Change How We Vote. Will He Succeed?

This week, the Senate is debating the contentious SAVE America Act, a strict voter identification bill that could overhaul who gets to vote. President Trump has called it his “No. 1 priority,” threatening to not sign any other legislation until it is passed. Michael Gold and Nick ...  Show more

Who Is Winning the War in Iran?

Nearly three weeks into the war in Iran, the United States and Israel have largely decimated the regime’s missile capacity, taken out key leaders and disrupted its central command. Yet, the regime in Iran has become more hardened and is wreaking more havoc than ever. Eric Schmitt ...  Show more

Recommended Episodes

The pandemic is officially a year old. We've learnt so much.
What's That Rash?

A year ago today, the World Health Organisation officially declared the coronavirus outbreak a "pandemic". In reality, it'd been clear for some time that the SARS-CoV-2 virus wasn't going to go away anytime soon. Cases outside China had been growing fast and Italy was going into ...  Show more

Omicron's Arrival Is 'Wake-Up Call' That The Pandemic Is Ongoing
Short Wave

The coronavirus is still circulating and mutating — case in point, the World Health Organization has designated a new variant of concern, called omicron. The variant appears to have some characteristics that may make it more transmissible than others, but much about it is still u ...  Show more

A Vaccination Update And The CDC's Latest Guidance On Masks
Short Wave

The rate of vaccination in the U.S. continues to slow. Maddie Sofia talks with NPR health correspondent Allison Aubrey about that and what can be done to get more people vaccinated. Also, making sense of the CDC's latest mask guidance. Have questions about the latest coronavirus ...  Show more

Are all viral vector vaccines a problem?
What's That Rash?

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Show more